Gilead Sues U.S. Government, Claiming CDC Breached Contracts Requiring Notification Of Patent Filings On HIV Drug

STAT: Gilead sues U.S., claiming it ‘secretly’ obtained patents on HIV research that led to Truvada
“Gilead Sciences (GILD) has accused the U.S. government of breaching several contracts and ‘secretly’ obtaining patents stemming from research that led to the ground-breaking Truvada HIV-prevention pill. In a lawsuit filed late Friday, the drug maker claimed the Centers for Disease Control and Prevention violated the terms of a 15-year-old collaboration by failing to notify the company of patents that were later sought and awarded on the research…” (Silverman, 4/26).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.